Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy

被引:12
作者
Koslowski, Michael [1 ,2 ,3 ,4 ]
Johnson, Matthew W. [5 ]
Gruender, Gerhard [6 ]
Betzler, Felix [1 ,2 ,3 ,4 ]
机构
[1] Charite Univ Med Berlin, Klin Psychiat & Psychotherapie, Campus Charite Mitte, D-10117 Berlin, Germany
[2] Free Univ Berlin, D-10117 Berlin, Germany
[3] Humboldt Univ, D-10117 Berlin, Germany
[4] Berlin Inst Hlth, D-10117 Berlin, Germany
[5] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[6] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Neuroimaging, Mannheim, Germany
关键词
Psychedelics; LSD; Psilocybin; Psychotherapy; Psychodynamic; CBT; Addiction; LYSERGIC-ACID DIETHYLAMIDE; LIFE-THREATENING CANCER; ASSISTED PSYCHOTHERAPY; PSILOCYBIN TREATMENT; COMMITMENT THERAPY; ALCOHOL DEPENDENCE; AYAHUASCA; LSD; HALLUCINOGENS; EXPERIENCES;
D O I
10.1007/s40429-021-00401-8
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Purpose of Review The use of psychedelics in a therapeutical setting has been reported for the treatment of various diagnoses in recent years. However, as psychedelic substances are still commonly known for their ( illicit) recreational use, it may seem counterintuitive to use psychedelic therapy to treat substance use disorders. This review aims to discuss how psychedelics can promote and intensify psychotherapeutic key processes, in different approaches like psychodynamic and cognitive behavioral therapy, with a spotlight on the treatment of substance use disorders (SUD). Recent Findings There is promising evidence of feasibility, safety, and efficacy of psychedelic therapy in SUD. In the whole process of former and current psychedelic therapy regimes that have shown to be safe and efficacious, various psychotherapeutic elements, both psychodynamic and behavioral as well as other approaches, can be identified, while a substantial part of the assumed mechanism of action, the individual psychedelic experience, cannot be distinctly classified to just one approach. Summary Psychedelic therapy consists of a complex interaction of pharmacological and psychological processes. When administered in well-defined conditions, psychedelics can serve as augmentation of different psychotherapy interventions in the treatment of SUD and other mental disorders, regardless of their theoretical origin.
引用
收藏
页码:48 / 58
页数:11
相关论文
共 50 条
  • [1] Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy
    Michael Koslowski
    Matthew W. Johnson
    Gerhard Gründer
    Felix Betzler
    Current Addiction Reports, 2022, 9 : 48 - 58
  • [2] The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
    Hogea, Lavinia
    Tabugan, Dana Catalina
    Costea, Iuliana
    Albai, Oana
    Nussbaum, Laura
    Cojocaru, Adriana
    Corsaro, Leonardo
    Anghel, Teodora
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [3] The Contribution of Psychotherapy in Potential Therapeutic Effects of Psychedelics for Treatment of Opioid Use Disorder
    Nia, Anahita Bassir
    Farahmand, Yalda
    Griffith, Garret
    Ardavan, Mohammad Aghaei
    Angarita, Gustavo A.
    Anand, Akhil
    Pittenger, Christopher
    CURRENT ADDICTION REPORTS, 2025, 12 (01)
  • [4] Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
    DiVito, Alec J.
    Leger, Robert F.
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (12) : 9791 - 9799
  • [5] The resurgence of psychedelics: a review of their neurobiology and use in mental disorders and addiction
    Dehanov, Sara
    Ferreira, Tiago
    Figueiredo, Ines
    PSILOGOS, 2021, 19 (1-2) : 43 - 56
  • [6] Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
    Richard, Jeremie
    Garcia-Romeu, Albert
    CURRENT ADDICTION REPORTS, 2025, 12 (01)
  • [7] Psychedelics in the Treatment of Substance Use Disorders
    Barnett, Brian S.
    Weleff, Jeremy
    PSYCHIATRIC ANNALS, 2022, 52 (09) : 365 - 370
  • [8] Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders
    Wong, Stanley
    Yu, An Yi
    Fabiano, Nicholas
    Finkelstein, Ofer
    Pasricha, Aryan
    Jones, Brett D. M.
    Rosenblat, Joshua D.
    Blumberger, Daniel M.
    Mulsant, Benoit H.
    Husain, M. Ishrat
    JOURNAL OF PSYCHOACTIVE DRUGS, 2024, 56 (04) : 513 - 529
  • [9] Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders
    Valdez, Tamara
    Patel, Valbhi
    Senesombath, Nattaphone
    Hatahet-Donovan, Zayd
    Hornick, Mary
    PHARMACEUTICALS, 2024, 17 (11)
  • [10] The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
    dos Santos, Rafael Guimaraes
    Carlos Bouso, Jose
    Rocha, Juliana Mendes
    Rossi, Giordano Novak
    Hallak, Jaime E.
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2021, 14 : 901 - 910